- Home
- MEDP vs LPX Comparison
MEDP vs LPX Comparison
Compare MEDP & LPX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MEDP
- LPX
- Stock Information
- Founded
- MEDP 1992
- LPX 1973
- Country
- MEDP United States
- LPX United States
- Employees
- MEDP N/A
- LPX N/A
- Industry
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- LPX Forest Products
- Sector
- MEDP Health Care
- LPX Basic Materials
- Exchange
- MEDP Nasdaq
- LPX Nasdaq
- Market Cap
- MEDP 10.5B
- LPX 8.5B
- IPO Year
- MEDP 2016
- LPX N/A
- Fundamental
- Price
- MEDP $337.35
- LPX $114.92
- Analyst Decision
- MEDP Buy
- LPX Hold
- Analyst Count
- MEDP 10
- LPX 10
- Target Price
- MEDP $389.00
- LPX $104.78
- AVG Volume (30 Days)
- MEDP 226.7K
- LPX 688.2K
- Earning Date
- MEDP 02-10-2025
- LPX 02-12-2025
- Dividend Yield
- MEDP N/A
- LPX 0.90%
- EPS Growth
- MEDP 33.84
- LPX 276.87
- EPS
- MEDP 11.42
- LPX 5.81
- Revenue
- MEDP $2,070,866,000.00
- LPX $2,919,000,000.00
- Revenue This Year
- MEDP $13.95
- LPX $14.06
- Revenue Next Year
- MEDP $5.49
- LPX $4.82
- P/E Ratio
- MEDP $29.49
- LPX $19.78
- Revenue Growth
- MEDP 16.24
- LPX 11.07
- 52 Week Low
- MEDP $286.76
- LPX $63.76
- 52 Week High
- MEDP $459.77
- LPX $122.87
- Technical
- Relative Strength Index (RSI)
- MEDP 47.28
- LPX 61.12
- Support Level
- MEDP $327.00
- LPX $104.25
- Resistance Level
- MEDP $359.63
- LPX $113.88
- Average True Range (ATR)
- MEDP 9.20
- LPX 2.93
- MACD
- MEDP -0.72
- LPX 1.31
- Stochastic Oscillator
- MEDP 31.73
- LPX 78.58
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.
About LPX Louisiana-Pacific Corporation
Louisiana-Pacific is primarily an oriented strand board producer and also offers engineered wood siding used in home construction and repair and remodel projects. The company is largely exposed to the North American housing market but has also established capacity in Brazil and Chile.